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ABSTRACT The mfluence of HLA mismatches be- 
tween donor and recipient on the phenotypes, function, 
and specificity of T-lymphocyte cultures derived from en- 
domyocardial biopsies was studied in 118 heart transplant 
recipients In case of HLA-DR mismatches, the malorlty 
of the EMB-derived cultures were dommated by CD4 ÷ T 
cells while, in patients with HLA-A and -B mismatches 
but without DR mismatches, CD8 ÷ T cells comprised 
the predommant T-cell subset Cytotoxiclty against do- 
nor antigens was observed in 75% of the cultures A 
significantly (p < 0 005) lower proportion of the cultures 
showed cytotoxiclty against HLA-A antigens (36%) when 
compared with HLA-B (53%) or HLA-DR (49%) An 
HLA-A2 mismatch elicited a cytotoxlc response that was 
comparable to that found against HLA-B and -DR anti- 
gens 62% of the cultures from HLA-A2 mismatched 
donor-rec,plent combinations was reactive against A2 A 
higher number of A, B, or DR mismatches resulted m a 
higher number of cytotoxlc ultures directed against hese 
antigens A higher number of HLA-B and -DR mis- 
matches was associated with a lower freedom from relec- 
tion Our data indicate that, despite the use of adequate 
immunosuppresslve therapy, the degree of HLA match- 
Ing plays a crucial role in the immune response agamst a 
transplanted heart, resulting m a s,gmficant effect on 
freedom from re}ection Human Immunology 39, 233-242 
(1994) 
ABBREVIATIONS 
CTL cytotoxic T lymphocyte 
CTLp cytotox~c T-lymphocyte precursor 
EBV Epstein-Barr virus 
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PHA 
endomyocardial biopsy 
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INTRODUCTION 
Products  of the ta i lo r  h l s tocompat ,b lh ty  complex  
(MHC) play a major role m the immune response agamst 
a transplanted organ [ I ,  2] In extensive studies m kid- 
ney t ransplant  rec~p,ents, a pos~t,ve effect of HLA 
matchmg on graft survlval was reported, especlally for 
HLA-B and -DR antigens [3 -8 ]  The beneficial effect of 
DR matchmg was found to be most evident m the first 
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postoperative months, while the effect of matching for 
HLA-B antigens lasted longer These studies were based 
on the assumption that all of the HLA alleles had the 
same antigenic weight Busson and coworkers [9] 
showed, in kidney transplant recipients with only one 
incompatible HLA-antigen, that some of the HLA-A 
antigens were associated with a lower transplant survival 
than others, while at the B locus, there was no signifi- 
cant difference in survival rate among the different an- 
tigens 
The importance of HLA matching for heart allograft 
survival is still debated, mainly because of the limited 
numbers of patients tudied and, more importantly, the 
low numbers of well-matched grafts performed, as donor 
hearts are randomly allocated without reference to HLA 
matching Nevertheless, a beneficial effect of HLA 
matching has been found for cardiac graft survival [ 10, 
11], the incidence of steroid-resistant relectlon [12], or 
the freedom from relectlon of the transplanted heart 
[13] 
Acute allograft relection is mediated by lmmunocom- 
petent lymphocytes of the graft recipient hat interact 
with allogeneic determinants expressed on the grafted 
organ Recognition of both HLA class I and class II 
allogenelc differences by both helper and cytotoxic T 
lymphocytes (CTLs) precipitates a cascade of reactions 
that results in a cytotoxic response directed against cells 
bearing these antigens, and thus In parenchymal damage 
of the graft tissue [ 14-20] In previous tudies [21-25], 
we and other showed that graft-infiltrating lymphocytes 
can be cultured from cardiac graft tissue specimens Dur- 
ing acute relection episodes, a higher proportion of these 
biopsies yielded lymphocyte cultures, of which the ma- 
Iority was cytotoxic against donor-derived cells 
The influence of HLA mismatches between donor and 
recipient on phenotypes and effector function of graft 
infiltrating cells has never been systematically studied 
Therefore we analyzed the effect of HLA-A, -B, and -DR 
mismatches on the functional and phenotypic haracter- 
istics of these cells in a large series of endomyocardIal 
biopsies (EMBs) from 118 heart transplant recipients 
Moreover, we investigated the lmmunogenlcIty of indi- 
vidual mismatched HLA antigens 
MATERIALS AND METHODS 
Patients 
We studied EMB-derIved graft-infiltrating cells from 
118 heart transplant recipients who underwent rans- 
plantations between February 1988 and January 1990 
All patients had received preoperative blood transfusions 
and all received cyclosporine and low-dose prednIsone as 
maintenance lmmunosuppressIon The actuarial patient 
surwval was 89% at 4 years The mean number of mls- 
matches between donor and recipient was 1 25, 1 62, 
and 1 40 for HLA-A, -B, and -DR, respectively Table 
1 shows the distribution of the patients among the dlf- 
ferent matched groups HLA hlstocompatiblhty was 
based on matching for broad specIficitmes Homozygosl- 
ties were considered as one mismatched antigen 
Relectlon was monitored by EMB Grading of the 
biopsies was according to Bilhnghams [26] criteria of 
none, mild, moderate, and severe rejection For the di- 
agnosis of moderate relectlon, the coexistence ofmyocyte 
necrosis and mononuclear Infiltrates was required In 
that case, antirejectlon treatment was instituted, which 
consisted of bolus steroids or, In case of ongoing relec- 
tlon, of a 2-week course of a polyclonal rabbit anti- 
thymocyte-globuhn preparation There were no cases of 
severe relectlon In the early posttransplant period, serial 
biopsy specimens were obtained at weekly intervals 
Later, EMBs were taken less frequently, declining to 
once very 4 months at 1 year After an acute relectlon 
episode, the next biopsy sample was taken 1 week fol- 
lowing relectIon therapy Three patients who died 
within 3 weeks after transplantation (from other causes 
than severe relectlon) were excluded from this study We 
received a total of 1285 EMBs, 4-22 from each patient 
(median, 10) 
HLA Typmg 
Spleen cells or peripheral blood mononuclear cells (oh- 
tamed by Flcoll separation of heparinlzed blood) were 
typed for HLA class I antigens according to the standard 
National Institutes of Health lymphocytotoxlcity assay, 
and typed for HLA-DR by the two-color fluorescence 
assay with a set of highly selected antlsera [27] 
Culture Method 
Lymphocyte cultures These were established from EMBs as 
described previously [21] In brief, each biopsy specimen 
was divided into two or more fragments and placed into 
two or more wells of a 96-well round-bottom tissue cul- 
ture plate (Costar 3799, Cambridge, MA, USA) with 
200-btl culture medium in the presence of 105 Irradiated 
(40 Gy) autotogous peripheral blood mononuclear cells as 
TABLE 1 Distribution of the 118 patients among 
the different mismatched groups 
Number of pat,ents 
HLA 0 MM a l MM 2 MM 
A 11 67 40 
B 4 40 74 
DR 9 53 56 
a MM, m~smatch 
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feeders Culture medium consisted of RPMI-1640- 
Dutch mo&ficatlon (Glbco, Paisley, Scotland) supple- 
mented with 10% vol/vol lecnn-free Lymphocult-T-LF 
(Bmtest, Dreamch, Germany) as exogenous source of IL- 
2, 10% pooled human serum, 4 mM L-glutamine, 100 
IU/ml penlcllhn, and 100 Dg/ml streptomycin When 
growth was observed, the contents of several wells of a 
culture were pooled and transferred to more wells when 
sufficient cell density was reached (105-106 cells/ml) 
When growth was slowing down or cell death was ob- 
served, the cultures were resnmulated by adding rather 
105 Irradiated (40 Gy) donor spleen cells/well or 5 × 103 
Epstem-Barr virus (EBV)-transformed donor cells/well 
0rradIated w,th 80 Gy) Only 6% of the cultures needed 
restimulatlon In order to obtain sufficient amounts of 
cells for a cell-medmted cytotoxlclty assay 
Allogenelc sttmulator/target ~ells Phytohemagglutmin 
(PHA) blasts were obtained by culturing spleen cells for 
at least 5 days m the presence of i% PHA-M (Dffco, 
Detroit, MI, USA) and culture medium RPMI 1640 
+ 5% pooled human serum and 5% lymphocult-T 
(Biotest) EBV-transformed B-cell hnes were set up and 
cultured as previously described [28] 
Phenotypm Analysis 
The phenotypes of the graft-infiltrating lymphocytes 
were analyzed by two-color flow cytometry after sta, ning 
with monoclonal antibo&es &rected against CD8 (ant,- 
leu2) and CD4 (antl-leu3), both purchased from Becton 
Dickinson (Mountain Vmw, CA, USA) The annbodms 
were directly conlugated to fluoresce, n or phycoerythrin 
A more extensive phenotypic haractenzatmn of the cul- 
tured cells is described elsewhere [21] A T-cell subset 
was considered to be predominant when xt comprised 
more than 60% of the cells m a culture 
Cell-Mediated Cytotoxlclty Assays 
Biopsy-derived bulk cultures were tested for donor- 
directed cytotoxlc~ty in a standard 4-hour 5ICr-release 
assay according to the European Standard Techmque 
[29] As target cells we used donor-derived cell lines and 
a panel of unrelated target cells (PHA T-cell blasts or 
EBV-transformed B-cell lines) sharing one or more HLA 
antigens with the donor, and a third-party control The 
speoficity for donor HLA class I (HLA-A and -B) or class 
II (HLA-DR) antigens was determined by testing the 
cytotoxlcity of the bmpsy-derlved T-cell hnes against a 
panel consisting of 5-10 (median, 7) target cell lines 
Each ln&vldual HLA anugen was represented I--4 times 
m the cell panels If the cytotoxxclty against an HLA 
antigen was difficult to interpret, such as the example of 
HLA-B15 m Fig 1 (left panel), this antigen was con- 
sldered to be not tested The HLA antigens tu&ed m 
the present report are hsted in Table 2 
51Cr-labeled target cells, 2 5 × 10 ~, were mixed w~th 
effector cells in 200 b~l culture medmm per well m 96- 
well U-bottom m,crotiter plates (Costar) Serial double 
&lunons wlth effector-target ratios varying from 1 25 1 
up to 80 1 were used The plates were incubated for 4 
hours at 37°C in 5% CO 2 Supernatants were harvested 
with a Skatron harvesting system (Skatron-AS, Norway) 
and the release of 5 iCr was assayed in a Packard gamma- 
counter (Packard Instruments, Downers Grove, USA) 
According to the recommendations of the European CML 
Workshop [29], cultures were considered cytolytic when 
the experimental lysls percentage xceeded 10% at an 
effector-target ratio of 20 1 or greater, and the slope of 
a graph was positive Some representative cytotoxxclty 
txtratlons are represented in Fig I Series of double- 
dflunon studies revealed that lysls percentages of autol- 
ogous control cell lines did not exceed 10% 
Statistical Analysis 
The slgmficance of differences among the various groups 
of panents and cultures was analyzed by Mann-Whitney 
test or by chl-squared test, respectively Freedom from 
relectmn rates were computed by actuarial methods and 
stanstical slgmficance was estimated by log-rank analy- 
sis 
RESULTS 
HLA mlsnaatches and acute re/ectlon In the DR-matched 
patient group 56% of pauents remained free from rejec- 
non at 6 months, compared with 29% of patients with 
one and 22% with two DR mismatches with thmr do- 
nors For the combinatmn of HLA-B and -DR antigens 
a significant effect on freedom of relectton was observed 
(p < 0 05, Fig 2) Transplants with two or fewer mis- 
matched HLA-B and -DR antigens displayed a 14% 
h,gher freedom from relectxon at 6 months compared 
with those with three or four HLA-B and -DR incom- 
patibilities The number of HLA-A mismatches did not 
show any addmve ffect on freedom from rejection rates 
No sigmficant relation between the number of acute 
relecnon episodes and the number of mismatches on the 
individual A, B, or DR locus was observed 
HLA mzsmatches and CD4/CD8 phenotypes From all pa- 
nents, approximately 60% of the EMBs yielded lympho- 
cyte cultures The success of culturing did not depend on 
the degree of HLA-DR matching between donor and 
recipient, since the mean percentages growing biopsy 
specimens were highly comparable m patients with zero, 
one, or two DR mismatches with their donors (57%, 
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FIGURE 1 Representatwe example of a positive (left) and a 
negative cytotoxicity titrauon (right) of biopsy-derived cul- 
tures from two different patients The cultures were not re- 
stimulated with donor cells and were cultured for 40 and 26 
days, respectively In these examples, EBV-transformed B-cell 
lines were used as targets The HLA antigens hared by target 
cells and the heart donor are indicated HLA typing (left) 
recipient A1, A10(25), B18, B35, DR2(w15), and 
DRw6(w 13), and donor A2, B 15(w62), B 18, DR2(w15), and 
DR3, and (right) recipient A2, A3, B35, B37, DR7, and 
DRwl0, and donor A10(26), A19(29), B12(44), B22(55), 
DR5(11), and DR7 
59%, and 63%, respectively) In the first 180 days after 
transplantation, the number of HLA-DR mismatches be- 
tween donor and recipient had a pronounced mfluence on 
the phenotyplc omposltzon of the EMB-derived lym- 
phocyte cultures (Fig 3) Recipients with HLA-A and 
-B m,smatches but without DR mtsmatches with their 
donors yielded cultures that were dommated by CD8 + T 
cells m 60% of cases (p < 0 005 compared with DR- 
mismatched combinattons) In cultures from patients 
wzth DR mismatches, CD4 ÷ T cells comprised the pre- 
dommant T-cell subset The predommance of CD4 ÷ T 
cells was most ewdent m patients with two DR mis- 
matches with their donors (p = 0 025 compared with 
DR-matched combmatmns) After the first 6 posttrans- 
plant months, no slgmficant differences between the 
groups were found 
The mfluence of the degree of HLA class I matchmg 
on growth and phenotyplc omposltlon of the cultures 
was hard to evaluate, because all patients except one had 
one or more class I mlsmatches The EMB-denved cul- 
tures (n = 7) from this stogie patient were all dominated 
by CD4 + T cells In the remainmg patlents, no slgnIf- 
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leant relatmn was found between the number of HLA 
class I mismatches and the degree ofCD8 predommance 
Cytotoxlczty In vitro studies showed that the malority (n 
= 234 or 75%) of the tested EMB-derlved T-lympho- 
cyte cultures (n = 324) was cytotoxlc against donor 
antigens Of these cultures, 165 (53%) and 154 (49%) 
were cytotoxlc against HLA-B and -DR antigens, respec- 
tlvely Significantly fewer cultures (n = 107, 36%, p < 
0 005) showed cytotoxlclty against HLA-A antigens 
This higher immunogentclty of HLA-B and -DR anti- 
gens was also apparent when we analyzed the CTL reac- 
tivity against several individual HLA antigens (Table 2) 
This was analyzed for broad specifiCltles and not splits 
Agamst most HLA-A antigens a low percentage of reac- 
tive cultures was found Only HLA-A2 was found to be 
of comparable immunogeniclty to HLA-B and -DR an- 
tigens Of  the 90 tested cultures from 23 donor-  
recipient combinations with an HLA-A2 incompatibil- 
ity, 62% showed reactivity against A2, which was sig- 
nificantly higher than generally found against other 
HLA-A antigens (p < 0 001, Table 2) When analyzed 
as the percentage reactive cultures for each individual 
patient, a median of 60% HLA-A2-reactlve cultures was 
found, which was agam significantly higher than against 
other m~smatched HLA-A antigens (p < 0 001, Fig 4) 
Among the HLA-B antigens, no evidence for such an 
immunodominant locus allele was found Generally, a 
high percentage of tested cultures showed cytotoxlclty 
agamst mismatched HLA-B antigens, while against 
some of these antigens the reactwlty was lower (Tables 2 
and 3) A slmflar pattern was found for reactivity agamst 
HLA-DR mismatches (Table 3) 
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TABLE 2 CML reactivity of EMB-derlved 
lymphocyte cultures against he most 
prevailing mismatched HLA antigens, 
expressed as numbers and percentages of
cultures reactive against an HLA antigen 
Number of cultures 
Positive in No of 
HLA MM a Tested CML (o~) patients tested 
HLA-A 
A1 7:5 18 (25) 24 
A2 90 56 (62) 23 
A3 58 19 (33) 22 
A10 38 7 (18) 12 
All 36 7 (19) 7 
Awl9 119 32 (27) 29 
HLA-B 
B5 58 23 (40) 11 
B7 46 21 (46) 19 
B8 54 23 (43) 14 
Bl2 68 38 (56) 19 
B18 34 13 (38) 11 
B27 21 11 (52) 7 
B35 59 32 (54) 15 
B40 37 9 (24) 15 
B15 30 4 (13) 9 
HLA-DR 
DR1 85 35 (41) 20 
DR2 42 17 (40) 16 
DR3 62 31 (50) 19 
DR4 72 33 (46) 17 
DR5 87 32 (37) 18 
DRw6 50 22 (44) 12 
DR7 59 29 (49) 16 
DRw8 37 10 (27) 10 
a MM, mismatch 
In time, donor-directed cytotoxiclty declined signifi- 
cantly (p < 0 03), from 79% (181 of 229) of the cultures 
established from EMB taken in the first 180 days to 61% 
(58 of 95) after 6 months This was due to a fall in the 
percentage of cultures that were cytotoxtc against mis- 
matched onor HLA-B and -DR antigens (Table 4) 
A higher number of HLA-A, -B, or -DR mismatches 
between donor and recipient was found to be positively 
correlated with the percentage of cytotoxtc ultures di- 
rected against hese antigens (Table 5) Biopsy samples 
from patients with two A, B, or DR mismatches with 
their donors yielded a higher proportion of cytotoxlc 
cultures directed against hese antigens when compared 
with EMB from patients who had only one mismatch for 
any of these HLA antigens The pronounced ose effect 
of HLA-A mismatches was mainly found when the sec- 
ond HLA-A anngen was A2 (in 62% of cultures from 
donor-recipient combinations with two HLA-A mis- 
matches and a positive CML against HLA-A, compared 
% 
25 I 
0 • d ±_  L J 
0 4 8 12 16 20 24 
WEEKS AFTER HEART TRANSPLANTATION 
- -  2 OR LESS MM - -  3 OR 4 MM 
32 pat ients 86  pat ients  
FIGURE 2 Actuarial freedom from relectlon of heart trans- 
plants in relation to matching for HLA-B and -DR antigens 
The freedom from rejecnon of patients with ~<2 or >3 mis- 
matches for the combined B and DR antigens were 65°~ and 
42% at 2 months (p = 0 01), and 37% and 24% at 6 months 
(p = 0 05), respectively 
with only 28% of cultures not reactive against HLA-A, 
p < 0001,  X 2test) 
DISCUSSION 
The present study shows that the number of mismatched 
HLA-B and -DR antigens on a transplanted heart, but 
also HLA-A antigens, is positively correlated with the 
percentage of cytotoxlc EMB-dertved cultures directed 
against hese mismatched HLA antigens The incidence 
of HLA-A-dlrected cytotoxictty was lower, however, 
than that directed against B or DR mismatches This 
apparently high tmmunogemcity of HLA-B and -DR 
antigens may account for the significantly lower freedom 
from relection rates In the patient group with more than 
two HLA-B and -DR mismatches This association be- 
tween the number of HLA-B and -DR mismatches and 
freedom from relectton has also been described by others 
[13] Studies on the effect of matching for HLA antigens 
in renal [3-8] and heart transplantation [10, 11] showed 
that matching for HLA-B and -DR has a stgmficant 
influence on graft survival In normal individuals 
HLA-B antigens are more lmmunogemc to cytotoxic T 
cells than HLA-A antigens, although major individual 
differences were found in the frequency of alloreacnve 
CTL precursor (CTLp) directed against HLA class I [30- 
33] and class II [34] antigens Until now, a direct cot- 
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FIGURE 3 Predominant phenotype of EMB-derlved lym- 
phocyte cultures an relation to the number of HLA-DR mis- 
matches (MM) between donor and recipient In the first 180 
days after transplantation, cultures from patients without DR 
mismatches with their donors were most often dominated by 
CD8 + cells (p < 0 005 compared with DR-matched combi- 
nations), while in cultures from patients with DR mismatches 
CD4 ÷ T cells comprised the predominant subset In the ma- 
lority of cultures (left) After the first 6 posttransplant 
months, no significant differences between the groups were 
found (right) Numbers of cultures tested (left) 0 DR MM (n 
= 22), 1DRMM(n = 160), and2DRMM(n = 226),and 
(right) 0DRMM(n ~- 17), 1DRMM(n = 106), and 2 DR 
MM (n = 110) 
relation between pretransplant CTLp frequencies and 
transplant outcome has not been shown But ~t was 
found in mice that an mcrease of CTLp frequency after 
transplantation is associated with allograft relectlon 
[35] In renal transplant patients, a decrease of donor- 
specific CTLp is correlated with good graft function 
[36], and a low patient-specific CTLp frequency in a 
bone marrow donor glves less graft-versus-host d~sease 
[37] 
In the present study, a "dose-effect" phenomenon of 
the number of mismatches on CML reactivity was found 
for HLA-A, -B, and -DR antigens This dose--effect phe- 
nomenon of HLA mismatches could also be observed m 
the higher 6-month freedom from relectlon m patients 
with two or fewer HLA-B and -DR mlsmatches m the 
> 180 DAYS 
% OF CULTURES TESTED 
100 m CD4 ~ CD8 
6O 
40 
20 
0 1 2 
DR MISMATCHES 
first half year This is consistent wlth data of Opelz [3, 
10, 38], who showed that during the early posttrans- 
plant course, HLA-B and -DR mismatches exerted a 
strong mfluence on transplant survival, m contrast to 
mismatched HLA-A antigens However, the mfluence of 
the latter on long-term survival was comparable to that 
of HLA-B and -DR antlgens [38] Interestingly, the 
dose effect for HLA-A mismatches was mainly found 
when the second mismatched antigen on the A locus 
was A2 
Our finding of hlgh reactivity against HLA-A2 anti- 
gens expressed on donor cells confirms the observation of 
others [33] (Roelen, personal commumcat ion)  that 
HLA-A2 is an immunodomlnant locus allele They 
found high anti-A2 CTLp frequencies among normal 
mdlvlduals and m hlghly sensitized patients awaiting 
renal transplantation, respectively By Inhibition exper- 
iments w~th CD8 monoclonal antibodies, it was shown 
that all antl-HLA-A (lncludmg A2) CTLps could be in- 
hibited, lndlcatmg that these cytotoxlc T cells have a low 
avldlty for HLA-A antlgens Of HLA-B-dlrected CTLs, 
slgmficantly fewer could be mhlblted In previous re- 
ports [39, 40], we have shown that low-awdlty allore- 
actwe CTLs are probably not relevant for the rejection 
process Hlgh-awdlty alloreactlve CTLs can be demon- 
strated in the peripheral blood of highly sensltlzed can- 
dldates for renal (re)transplantation, and xn the grafts of 
relectmg heart transplant recipients Interestingly, pre- 
hmmary data from Eurotransplant (Thorogood) show 
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FIGURE 4 Percentage cytotoxlc cultures against individual 
mismatched HLA-A anngens Each dot represents one patient 
From each patient, 1-12 (me&an, 4) bmpsy-denved cultures 
could be tested Against an HLA-A2 mismatch, a significantly 
higher percentage of reacnve cultures was found when com- 
pared with other mismatched HLA-A anngens (p < 0 001, 
Mann-Whitney test) Medians of a group are *ndIcated as 
horizontal hnes 
TABLE 3 CML reactlwty 
against m~smatched 
HLA-B and -DR 
anngens, expressed 
as medlan 
percentage reactive 
cultures per patmnt 
group with this 
HLA mcompanblhty 
Me&an percentage 
reactive cultures 
HLA-B 
B5 22 
B7 50 
B8 38 
B12 60 
B 18 60 
B27 50 
B35 6O 
B40 0 
B15 0 
HLA-DR 
DR1 45 
DR2 2:~ 
DR3 4O 
DR4 67 
DR5 33 
DRw6 22 
DR7 40 
DRw8 6 
From each patient, 1-12 (me&an, 4) bmpsy- 
derived cultures could be tested 
TABLE 4 CML speclfioty of EMB-denved cultures 
against panel cells sharing mismatched 
HLA-A, -B, or -DR anugens wlth the 
donor relatmn wtth time 
after transplantanon 
Number of reactive cultures 
< 180 days > 180 days 
CML specificity n (~)a n (%) pa 
HLA-A 79 (38) 28 (33) NS 
HLA-B 127 (57) 38 (40) <0 01 
HLA-DR 120 (55) 34 (37) <0 01 
In the first half-year,the incidence of HLA-A-&rected cytotoxlclty was slg- 
mficantly lower than that agamst B or DR anngens (p < 0 001) 
Number and percent of reacnve cultures 
h X2 test 
that a mismatch for HLA-A2 does not result m a lower 
kidney transplant survival In the present study, this 
could not be evaluated, because all panents also had 
several HLA-B and -DR mismatches with thmr donors 
In the one and two DR-mismatched groups, slgmfi- 
cantly more CD4-dommated cultures were derived from 
the bmpsles than in the DR-matched group CD4 + cells 
are known to be of crucial importance m the lnmatmn of 
rejecuon [14-20] Interacuon of these cells with donor 
class II MHC anngens expressed on the graft nssue and 
on passenger leukocytes of donor ongm results in acn- 
vanon of CD8 + cells that recognize MHC class I anu- 
gens Both CD4 + and CD8 + cells play a role m the 
relecuon of mismatched grafts [14-16] Relecnon of 
class I &sparate grafts appears to depend most on CD8 + 
cells, although CD4 + cells can be acnvated as well via 
presentatmn of donor MHC class I anngens on rec~p,ent 
antigen-presenting cells m the context of self-HLA class 
II molecules [41, 42] 
More than 180 days after transplantation, the dechne 
found m the number of the CD4-dommated cultures 
may be due to a lower expression of donor-type class II 
antigens on graft nssue, due to the replacement ofdonor 
dendritic cells by the pauents' antigen-presenting cells 
[43, 44] As a consequence, fewer class-II-speclfic 
CD4 + lymphocytes may be attracted to the graft Data 
from ammal heart transplant models show that this re- 
ductmn of the number of HLA class-II-expressmg den- 
dntlC cells may already start early after transplantatmn, 
wh,ch may explain our finding that m some patients an 
earher dechne of DR-&rected cytotoxmlty is found [45] 
(data not shown) 
Lower expressmn of donor-type HLA antigens on graft 
t~ssue may also play a role in the lower incidence of 
cytotoxlc,ty &rected against these antigens after 6 
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TABLE 5 The dose effect of the number of HLA 
mismatches per locus on CML reacnv,ty 
of EMB-denved cultures 
CML specificity 
Number of reacuve cultures 
1 MM a 2 MM 
n (~)b n (~) p' 
HLA-A 86 (34) 77 (52) 0 005 
HLA-B 78 (50) 145 (60) 0 055 
HLA-DR 73 (40) 119 (52) 0 025 
MM, mismatch 
b Number and percent of reactive cultures 
c )(2 tes t  
months [47, 48] Next to the mfluence of HLA expres- 
sion on the graft, other mechanisms may also be in- 
volved Spec,fic suppressmn of antldonor esponses by 
regulatory T cells, clonal anergy or deletmn of ant,donor 
T cells, or downmodulatmn by anmdmtyp,c ant,bodies 
are thought o be important mechamsms contribut,ng to 
acquired immune tolerance ,n human transplant rec,p> 
ents [21, 36, 48-50] 
In conclusmn, we showed that the number and nature 
of HLA mismatches between donor and rec,p,ent 
strongly mfluence the cellular ,mmune response w,thm 
the transplanted heart, resultmg in a s,gnificant effect on 
freedom from relectmn 
REFERENCES 
1 Dausset J, Hors J, Busson M, Festenstem H, Bact CBD, 
Path MRC, Oliver RTD, Chir B, Paris AMI, Sachs JA 
Serologlcally defined HL-A antigens and long-term sur- 
vival of cadaver kidney transplants a lolnt analysis of 918 
cases performed by France transplant and the London 
transplant group N Engl J Med 290 979, 1974 
2 van Rood JJ Leucocyte grouping a method and its ap- 
phcatmn Thesis, University of Leiden, Leiden, The 
Netherlands, 1962 
3 Opelz G Effect of HLA matchmg In 10,000 cyclospor- 
me-treated cadaver kidney transplants Transplant Proc 
19 641, 1987 
4 Thorogood J, Persljn GG, Schreuder GMTh, D'Amaro J, 
Zantvoort FA, van Houwehngen JC, van Rood JJ The 
effect of HLA matching on kidney graft survival in sep- 
arate posttransplantation mtervals Transplantation 50 
146, 1990 
5 Gllks WR, Gore SM, Bradley BA Renal transplant re- 
jectmn transient lmmunodommance of HLA mis- 
matches Transplantatmn 50 141, 1990 
6 Hendrlks GFJ, van Steenberge EPM, Schreuder GMTh, 
Wentlng GJ, Mochtar B, Bos E, Slmoons ML, Balk 
AHMM, Laird-Meeter K, Essed CE, Baumgarmer D, 
Jeekel J, Weimar W Treatment with cyclosporin and 
risks of graft relectIon in male kidney and heart transplant 
recipients with non-O blood BMJ 297 888, 1988 
7 Takiff H, Cook DJ, Hlmaya NS, Mlckey MR, Terasakl 
PI Dominant effect of histocompatlbihty and ten year 
kidney transplant survival Transplantation 45 410, 
1988 
8 Terasakl PI (ed) Chnlcal Transplants 1989, vol 3 Los 
Angeles, UCLA Tissue Typing Laboratory, 1989 
9 Busson M, Gony J, Hors J Is the strength of single HLA 
anngen mismatch variable in kidney transplant survlvaP 
Transplantation 28 313, 1979 
10 Opelz G Effect of HLA matching m heart transplanta- 
tion Transplant Proc 21 794, 1989 
11 Khagam A, Yacoub M, McCloskey D, Awad J, Burden 
M, Fitzgerald M, Hawes R, Holmes J, Smith J, Banner 
N, Festenstein H The influence of HLA matchmg, do- 
nor/recipient sex, and Incidence of acute relectIon on sur- 
wval in cardiac allograft recipients recelwng cyclosporIn 
A and azathloprlne Transplant Proc 21 799, 1989 
12 DISesa VJ, Kuo PC, Horvath KA, Mudge GH, Collins 
JJ, Cohn LH HLA hlstocompatlblhty affects cardiac 
transplant relecnon and may provide one basis for organ 
allocatmn Ann Thorac Surg 49 220, 1990 
13 Laufer G, Mlholic J, LaczkovIcs A, Wollenek G, Hol- 
zinger C, Halek-Rosenmeler A, Wuzl G, Schremer W, 
Buxbaum P, Wolner E Independent risk factors predict- 
ing acute graft rejection in cardiac transplant recipients 
treated by triple drug immunosuppression J Thorac Car- 
diovasc Surg 98 1113, 1989 
14 Lowry RP, Forbes RDC, Blackburn J, Marghesco D The 
pivotal role of cytotoxlc T cells in the rejecnon of heart 
grafts bearing isolated class I dIsparmes Transplant Proc 
27 227, 1985 
15 Lowry RP, Gurley KE, Clarke Forbes RD Immune 
mechanisms in organ allograft relection 1 Delayed-type 
hypersensmwty and lymphocytotoxiclty m heart graft re- 
lectIon Transplantation 36 391, 1983 
16 Lowry RP, Gurley KE Immune mechamsms m organ 
allograft rejection III Cellular and humoral Immumty in 
relection of organ allografts transplanted across MHC sub- 
region disparity RT1 B (RT1 D) Transplantatmn 35 
405, 1983 
17 Strom TB The cellular and molecular basis of allograft 
relectmn what do we know~ Transplant Proc 20 143, 
1988 
18 Bach FH, Sachs DH Transplantation Immunology N 
Engl J Med 317 489, 1987 
19 Hayry P Mechamsms of relectmn Curr OpIn Immunol 
1 1230, 1989 
20 Hall BM Transplantation tolerance a 1988 perspective 
Transplant Proc 21 816, 1989 
21 Ouwehand AJ, Vaessen LMB, Baan CC, Jutte NHPM, 
Balk AHMM, Essed CE, Bos E, Claas FHJ, Weimar W 
Alloreactive lymphmd infiltrates in human heart trans- 
plants loss of class II directed cytotoxlcity more than 
HLA Matchmg and AlloreactxvIty 241 
three months after transplantation Hum Immunol 30 
50, 1991 
22 Zeevi A, Fung JJ, Zerbe TR, Kaufman C, Rabm BS, 
Grlffith BP, Hardesty RL, Duquesnoy RJ Allospeclfictty 
of activated T cells grown from endomyocardlal biopsies 
from heart transplant patients Transplantation 41 620, 
1986 
23 Mayer TG, Fuller AA, Fuller TC, Lazarovxts AI, Boyle 
LA, Kurmck JT Characterization f in vlvo-activated al- 
lospeclfic T lymphocytes propagated from human renal 
allograft blopsxes undergoing relection J Immunol 
134 258, 1985 
24 Carlqulst JF, Hammond EH, Anderson JL Propagation 
and characterization f lymphocytes from relecting hu- 
man cardmc allografts J Heart Transplant 7 397, 1988 
25 Moreau JF, Bonneville M, Peyrat MA, Godard A, Jacues 
Y, Desgranges C, Souhllou JP T lymphocyte cloning 
from relected human kadney allografts J Clan Invest 78 
874, 1986 
26 Billingham ME Diagnosis of cardiac relection by endo- 
myocardial biopsy J Heart Transplant 1 25, 1982 
27 van Rood JJ, van Leeuwen A, Ploem JS Simultaneous 
detection of two cell populations by two-colour fluores- 
cence and application to the recogmtlon of B-cell deter- 
minants Nature 262 795, 1976 
28 Miller G, Shope T, Llsco H, Stltt D, Llpman M Ep- 
stein-Barr virus transformation cytopath~c hanges m 
sqmrrel monkeys and marmoset leucocytes Proc Nail 
Acad Sci USA 69 383, 1972 
29 European CML Workmg Group Human histocompatl- 
bflIty testing by T cell medmted lympholysls a European 
CML Standard techmque--report f om the European 
CML Workshop Tissue Antigens 16 335, 1980 
30 Breur-Vriesendorp BS, Vmgerhoed J, Schaasberg WP, 
Ivanyi P Variations in the T-cell repertoire against HLA 
antigens in humans Hum Immunol 27 1, 1990 
31 Sharrock EM, Man S, WanachawanawIn W, Batchelor 
JR Analysis of the alloreactlve T cell repertoire in man 
I Differences in precursor frequency for cytoxlc cell re- 
sponses agamst allogeneic MHC molecules m unrelated 
indlwduals Transplantation 43 699, 1987 
32 Zhang L, Guang S, Vandekerckhove B, Termxjtelen A, 
van Rood JJ, Claas FHJ Analysis of cytotoxlc T cell 
precursor frequencies directed agamst mdlvtdual HLA-A 
and -B alloantigens J Immunol Methods 121 39, 1989 
33 Breur-Vriesendorp BS, Vingerhoed J, van Twuyver E, de 
Waal LP, Ivanyl P Frequency analysis of HLA-speclfiC 
cytotoxlc T lymphocyte precursors an humans Transplan- 
tation 51 1096, 1991 
34 Man S, Lechler RI, Batchelor JR, Sharrock CEM Indi- 
vidual variation m the frequency of HLA class II-specific 
cytotoxic T lymphocyte precursors Eur J Immunol 20 
847, 1990 
35 Orosz CG, Zmn NE, Sirined L, Ferguson RM In vivo 
mechanisms of alloreactavlty I Frequency of donor- 
reactive T lymphocytes in sponge matrix allografts 
Transplantation 41 75, 1986 
36 Herzog WR, Zanker B, Irschxck E, Huber C, Franz HE, 
Wagner H, Kabehtz D Selective reduction of donor- 
specific T lymphocyte precursors an patients with a well- 
functioning kidney allograft Transplantation 43 384, 
1987 
37 Kamanskl E, Hows J, Man S, Brookes P, Mackinnon S, 
Hughes T, Avaklan O, Goldman JM, Batchelor JR Pre- 
diction of graft versus host disease by frequency analysis of 
cytotoxlc T cells after unrelated onor bone marrow trans- 
plantation Transplantation 48 608, 1989 
38 Opelz G Strength of HLA-A, HLA-B and HLA-DR mis- 
matches in relation to short- and longterm kidney graft 
survival Transplant Int 5(Suppl 1) $621, 1992 
39 Roelen D, Datema G, van Bree S, Zhang L, van Rood J, 
Claas F Evidence that antibody formation against a cer- 
tain HLA alloantlgen ~s associated not with a quantitative 
but with a quahtative change m the cytotoxic T cells 
recognizing the same antigen Transplantatxon 53 899, 
1992 
40 Ouwehand AJ, Baan CC, Roelen DL, Vaessen LMB, Balk 
AHMM, Jutte NHPM, Bos E, Claas FHJ, Weimar W 
The detection of cytotoxac T cells wath high affinity re- 
ceptors for donor antagens m the transplanted heart as 
prognostic factor for graft relect,on Transplantation 
56 1223, 199;5 
41 Liu Z, Braunstem NS, Suciu-Foca N T cell recognation 
of allopeptldes in context of syngeneic MHC J Immunol 
148 35, 1992 
42 Bemchou G, Takazawa PA, Olson CA, McMlllan M, Ser- 
carz EE Donor major histocompatibahty complex (MHC) 
peptldes are presented by rec~pxent MHC molecules dur- 
ang graft rejection J Exp Med 175 305, 1992 
43 Stemhoff G, Wonigeit K, Schafers HJ, HaverIch A Se- 
quential analysis of monomorphic and polymorphlc major 
h~stocompat~bxl~ty complex antigen expression m human 
heart allograft biopsy specimens J Heart Transplant 5 
360, 1989 
44 Sultters A, Rose M, Higglns A, Yacoub MH MHC an- 
tigen expression In sequential biopsies from cardiac trans- 
plant patients correlatxon wxth relectlon Clm Exp Im- 
munol 69 575, 1987 
45 Larsen CP, Morris PF, AustynJM Migration of dendritic 
leukocytes from cardmc allografts into host spleens a 
novel pathway for initmtion of relection J Exp Med 171 
307, 1990 
46 Suatters A, Rose M, Hlggins A, Yacoub MH MHC an- 
tigen expression in sequential biopsies from cardiac trans- 
plant patients correlation with relection Clin Exp Im- 
munol 69 575, 1987 
47 Bishop GA, Waugh JA, Hall BM Expression of HLA 
242 A J Ouwehand et al 
48 
antigens on renal tubular cells in culture II Effect of 
Increased HLA antigen expression on tubular cell stimu- 
lation of lymphocyte activation and on their vulnerability 
to cell-mediated lysls Transplantation 46 303, 1988 
Vandekerckhove BAE, Datema G, Konlng F, Goulmy E, 
Persljn GG, van Rood JJ, Claas FHJ, de Vries JE Anal- 
ysas of the donor-specific cytotoxlc T lymphocyte reper- 
toire m a patient with a long term surviving allograft 
frequency, specificity, and phenotype of donor-reactive T 
49 
50 
cell receptor (TCR) oLJ3 + and "r~ + cells J Immunol 144 
1288, 1990 
Mlyajlma T, Hlguchl R, Kashiwabara H, Yokoyama T, 
Fulimoto S Anti-idiotypic antibodies in a patient with a 
functioning renal graft Nature 283 306, 1980 
Suclu-Foca N, Reed E, Marboe C, Harris P, Ping XI Y, 
Yu-Kai S, Ho E, Rose E, Reemtsma K, King DW The 
role of antl-HLA antibodies m heart transplantation 
Transplantation 51 716, 1989 
